Sayali Dharmadhikari1,2, Cameron A Best1,3, Nakesha King4, Michaela Henderson5, Jed Johnson5, Christopher K Breuer1,6, Tendy Chiang1,2. 1. 1 Center for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA. 2. 2 Department of Otolaryngology, Nationwide Children's Hospital, Columbus, Ohio, USA. 3. 3 Biomedical Sciences Graduate Program, The Ohio State University College of Medicine, Columbus, Ohio, USA. 4. 4 Department of General Surgery, The Ohio State University, Columbus, Ohio, USA. 5. 5 Nanofiber Solutions, Inc, Hilliard, Ohio, USA. 6. 6 Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, Ohio, USA.
Abstract
OBJECTIVES: The clinical experience with tissue-engineered tracheal grafts (TETGs) has been fraught with graft stenosis and delayed epithelialization. A mouse model of orthotopic replacement that recapitulates the clinical findings would facilitate the study of the cellular and molecular mechanisms underlying graft stenosis. METHODS: Electrospun nanofiber tracheal scaffolds were created using nonresorbable (polyethylene terephthalate + polyurethane) and co-electrospun resorbable (polylactide-co-caprolactone/polyglycolic acid) polymers (n = 10/group). Biomechanical testing was performed to compare load displacement of nanofiber scaffolds to native mouse tracheas. Mice underwent orthotopic tracheal replacement with syngeneic grafts (n = 5) and nonresorbable (n = 10) and resorbable (n = 10) scaffolds. Tissue at the anastomosis was evaluated using hematoxylin and eosin (H&E), K5+ basal cells were evaluated with the help of immunofluorescence testing, and cellular infiltration of the scaffold was quantified. Micro computed tomography was performed to assess graft patency and correlate radiographic and histologic findings with respiratory symptoms. RESULTS: Synthetic scaffolds were supraphysiologic in compression tests compared to native mouse trachea ( P < .0001). Nonresorbable scaffolds were stiffer than resorbable scaffolds ( P = .0004). Eighty percent of syngeneic recipients survived to the study endpoint of 60 days postoperatively. Mean survival with nonresorbable scaffolds was 11.40 ± 7.31 days and 6.70 ± 3.95 days with resorbable scaffolds ( P = .095). Stenosis manifested with tissue overgrowth in nonresorbable scaffolds and malacia in resorbable scaffolds. Quantification of scaffold cellular infiltration correlated with length of survival in resorbable scaffolds (R2 = 0.95, P = .0051). Micro computed tomography demonstrated the development of graft stenosis at the distal anastomosis on day 5 and progressed until euthanasia was performed on day 11. CONCLUSION: Graft stenosis seen in orthotopic tracheal replacement with synthetic tracheal scaffolds can be modeled in mice. The wide array of lineage tracing and transgenic mouse models available will permit future investigation of the cellular and molecular mechanisms underlying TETG stenosis.
OBJECTIVES: The clinical experience with tissue-engineered tracheal grafts (TETGs) has been fraught with graft stenosis and delayed epithelialization. A mouse model of orthotopic replacement that recapitulates the clinical findings would facilitate the study of the cellular and molecular mechanisms underlying graft stenosis. METHODS: Electrospun nanofiber tracheal scaffolds were created using nonresorbable (polyethylene terephthalate + polyurethane) and co-electrospun resorbable (polylactide-co-caprolactone/polyglycolic acid) polymers (n = 10/group). Biomechanical testing was performed to compare load displacement of nanofiber scaffolds to native mouse tracheas. Mice underwent orthotopic tracheal replacement with syngeneic grafts (n = 5) and nonresorbable (n = 10) and resorbable (n = 10) scaffolds. Tissue at the anastomosis was evaluated using hematoxylin and eosin (H&E), K5+ basal cells were evaluated with the help of immunofluorescence testing, and cellular infiltration of the scaffold was quantified. Micro computed tomography was performed to assess graft patency and correlate radiographic and histologic findings with respiratory symptoms. RESULTS: Synthetic scaffolds were supraphysiologic in compression tests compared to native mouse trachea ( P < .0001). Nonresorbable scaffolds were stiffer than resorbable scaffolds ( P = .0004). Eighty percent of syngeneic recipients survived to the study endpoint of 60 days postoperatively. Mean survival with nonresorbable scaffolds was 11.40 ± 7.31 days and 6.70 ± 3.95 days with resorbable scaffolds ( P = .095). Stenosis manifested with tissue overgrowth in nonresorbable scaffolds and malacia in resorbable scaffolds. Quantification of scaffold cellular infiltration correlated with length of survival in resorbable scaffolds (R2 = 0.95, P = .0051). Micro computed tomography demonstrated the development of graft stenosis at the distal anastomosis on day 5 and progressed until euthanasia was performed on day 11. CONCLUSION: Graft stenosis seen in orthotopic tracheal replacement with synthetic tracheal scaffolds can be modeled in mice. The wide array of lineage tracing and transgenic mouse models available will permit future investigation of the cellular and molecular mechanisms underlying TETG stenosis.
Authors: Philipp Jungebluth; Evren Alici; Silvia Baiguera; Pontus Blomberg; Béla Bozóky; Claire Crowley; Oskar Einarsson; Tomas Gudbjartsson; Sylvie Le Guyader; Gert Henriksson; Ola Hermanson; Jan Erik Juto; Bertil Leidner; Tobias Lilja; Jan Liska; Tom Luedde; Vanessa Lundin; Guido Moll; Christoph Roderburg; Staffan Strömblad; Tolga Sutlu; Emma Watz; Alexander Seifalian; Paolo Macchiarini Journal: Lancet Date: 2011-11-24 Impact factor: 79.321
Authors: Jason D Roh; Rajendra Sawh-Martinez; Matthew P Brennan; Steven M Jay; Lesley Devine; Deepak A Rao; Tai Yi; Tamar L Mirensky; Ani Nalbandian; Brooks Udelsman; Narutoshi Hibino; Toshiharu Shinoka; W Mark Saltzman; Edward Snyder; Themis R Kyriakides; Jordan S Pober; Christopher K Breuer Journal: Proc Natl Acad Sci U S A Date: 2010-03-05 Impact factor: 11.205
Authors: Paolo Macchiarini; Philipp Jungebluth; Tetsuhiko Go; M Adelaide Asnaghi; Louisa E Rees; Tristan A Cogan; Amanda Dodson; Jaume Martorell; Silvia Bellini; Pier Paolo Parnigotto; Sally C Dickinson; Anthony P Hollander; Sara Mantero; Maria Teresa Conconi; Martin A Birchall Journal: Lancet Date: 2008-11-18 Impact factor: 79.321
Authors: Lumei Liu; Sayali Dharmadhikari; Robert A Pouliot; Michael M Li; Peter M Minneci; Zhenghong Tan; Kimberly Shontz; Jed Johnson; Susan D Reynolds; Christopher K Breuer; Daniel J Weiss; Tendy Chiang Journal: Bioengineering (Basel) Date: 2021-08-20
Authors: Lumei Liu; Sayali Dharmadhikari; Barak M Spector; Zheng Hong Tan; Catherine E Van Curen; Riddhima Agarwal; Sarah Nyirjesy; Kimberly Shontz; Sarah A Sperber; Christopher K Breuer; Kai Zhao; Susan D Reynolds; Amy Manning; Kyle K VanKoevering; Tendy Chiang Journal: J Tissue Eng Date: 2022-06-26 Impact factor: 7.940
Authors: Zheng Hong Tan; Sayali Dharmadhikari; Lumei Liu; Gabrielle Wolter; Kimberly M Shontz; Susan D Reynolds; Jed Johnson; Christopher K Breuer; Tendy Chiang Journal: Laryngoscope Date: 2021-06-21 Impact factor: 3.325
Authors: Lumei Liu; Sayali Dharmadhikari; Kimberly M Shontz; Zheng Hong Tan; Barak M Spector; Brooke Stephens; Maxwell Bergman; Amy Manning; Kai Zhao; Susan D Reynolds; Christopher K Breuer; Tendy Chiang Journal: J Tissue Eng Date: 2021-06-06 Impact factor: 7.940